Showing results (81-90 of 266) with videos related to
Sort By:
Pageof 27
Gut|October 16, 2020
Targeting the gut-liver-immune axis to treat cirrhosisThomas Henry Tranah, Lindsey A Edwards, Bernd Schnabl, et al.Molecular and Cellular Biology|January 30, 2004
TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b and is necessary for collagen type I synthesisBranko Stefanovic, Lela Stefanovic, Bernd Schnabl, et al.Gastroenterology|July 31, 2012
Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in micePhillipp Hartmann, Michael Haimerl, Magdalena Mazagova, et al.Metabolites|November 25, 2021
Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver DiseaseBei Gao, Yixin Zhu, Nan Gao, et al.The Journal of Experimental Medicine|July 20, 2007
MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infectionKatharina Brandl, George Plitas, Bernd Schnabl, et al.Cellular & Molecular Immunology|December 15, 2020
Gut microbiome, liver immunology, and liver diseasesRui Wang, Ruqi Tang, Bo Li, et al.Journal of Hepatology|May 27, 2021
The microbiota in cirrhosis and its role in hepatic decompensationJonel Trebicka, Jane Macnaughtan, Bernd Schnabl, et al.Hepatology (Baltimore, Md.)|September 25, 2014
Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in micePeng Chen, Peter Stärkel, Jerrold R Turner, et al.Journal of Gastroenterology|May 8, 2026
Covert hepatic encephalopathy as a multi-organ syndrome: the gut-liver-muscle-brain axis, diagnosis, treatment, and multidisciplinary careTakao Miwa, Cynthia L Hsu, Masahito Shimizu, et al.Journal of Hepatology|February 14, 2012
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver diseaseDerrick E Fouts, Manolito Torralba, Karen E Nelson, et al.Pageof 27